Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study
- PMID: 35292856
- DOI: 10.1007/s00394-022-02861-8
Dietary antioxidant supplements and risk of keratinocyte cancers in women: a prospective cohort study
Abstract
Purpose: Experimental studies suggested that antioxidants could protect against skin carcinomas. However, epidemiological studies on antioxidant supplement use in relation to basal-cell carcinoma (BCC) and squamous-cell carcinoma (SCC) risks yielded inconsistent findings, and few prospective studies have been conducted to date. We aimed to investigate the associations between antioxidant supplement intake and keratinocyte cancer (KC) risk.
Methods: E3N is an ongoing prospective cohort initiated in 1990 and involving 98,995 French women aged 40-65 years at recruitment. Intakes of dietary antioxidants were estimated via a validated dietary questionnaire in 1993 and self-reported antioxidant supplement use was collected in 1995. We used Cox models to compute hazard ratios (HRs) and 95% confidence intervals (CIs) adjusted for age and skin cancer risk factors.
Results: Over 1995-2014, 2426 BCC and 451 SCC cases were diagnosed among 63,063 women. We found positive relationships between vitamin A supplement use and KC risk (HR = 1.37, 95% CI 1.15-1.62), particularly with BCC (HR = 1.40, 95% CI 1.17-1.69); and between vitamin E supplement use and risks of both BCC (HR = 1.21, 95% CI 1.03-1.52) and SCC (HR = 1.43, 95% CI 1.03-1.99). Intake of beta-carotene supplements was associated with an increased SCC risk (HR = 1.59, 95% CI 1.00-2.54). Vitamin C supplement use was not associated with KC risk. We found similar results when considering total antioxidant intake.
Conclusions: Intakes of vitamin A or E supplements were associated with an increased KC risk in women. Further studies with information on doses and duration of supplement use and the ability to examine their underlying mechanisms are needed.
Keywords: Antioxidant supplements; Basal cell carcinoma; Keratinocyte cancer; Prospective cohort; Squamous cell carcinoma.
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.
References
-
- Urbach F (1991) Incidence of nonmelanoma skin cancer. Dermatol Clin 9:751–755 - DOI
-
- Lomas A, Leonardi-Bee J, Bath-Hextall F (2012) A systematic review of worldwide incidence of nonmelanoma skin cancer. Br J Dermatol 166:1069–1080. https://doi.org/10.1111/j.1365-2133.2012.10830.x - DOI - PubMed
-
- Staples MP, Elwood M, Burton RC et al (2006) Non-melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust 184:6–10 - DOI
-
- Christenson LJ, Borrowman TA, Vachon CM et al (2005) Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA 294:681–690. https://doi.org/10.1001/jama.294.6.681 - DOI - PubMed
-
- Joseph AK, Mark TL, Mueller C (2001) The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by medicare. Dermatol Surg 27:955–959 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
